„BIOMED-LUBLIN” WYTWÓRNIA SUROWIC I SZCZEPIONEK (Resolution No. 679/2020)

Resolution No. 679/2020
of the Management Board of the Warsaw Stock Exchange
dated 11 September 2020

concerning the admission and the introduction to exchange trading
on the GPW Main List of series B bearer ordinary shares
of the company „BIOMED-LUBLIN” WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A.

§ 1

The Warsaw Stock Exchange Management Board represents that pursuant to § 19.1-2 of the Warsaw Stock Exchange Rules, 794,000 series B bearer ordinary shares of the company „BIOMED-LUBLIN” WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A. a par value PLN 0.10 each, are admitted to exchange trading on the main market.

§ 2

Pursuant to § 36, § 37 and § 38.1 and § 38.3 of the Exchange Rules, and in connection with § § 3a.1, 3a.2 and § 3a.3 of the Exchange Rules, the Exchange Management Board resolves to introduce as of 15 September 2020 to exchange trading on the main market the shares of the company „BIOMED-LUBLIN” WYTWÓRNIA SUROWIC I SZCZEPIONEK S.A., mentioned in § 1, conditional on the registration of the series B shares and their coding as “PLBMDLB00018” by the National Depository for Securities on 15 September 2020.

§ 3

This Resolution shall take effect on the date of adoption.